VERV

Verve Therapeutics
VERV

Overview Fund Activity
Delisted

VERV was delisted on the 24th of July, 2025.

Back to rankings

125 hedge funds and large institutions have $912M invested in Verve Therapeutics in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 34 reducing their positions, and 18 closing their positions.

Holders
125
Holders Change
+3
Holders Change %
+2.46%
% of All Funds
2%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
21
Increased
42
Reduced
34
Closed
18
Calls
$1.98M
Puts
$485K
Net Calls
+$1.49M
Net Calls Change
-$6.36M

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$6.13M
2
Sumitomo Mitsui Trust Group
2
Sumitomo Mitsui Trust Group
Japan
$23M
3
NAMA
3
Nikko Asset Management Americas
New York
$22.4M
4
Citigroup
4
Citigroup
New York
$7.12M
5
Federated Hermes
5
Federated Hermes
Pennsylvania
$34.6M

Top Sellers

1
State Street
1
State Street
Massachusetts
$48.3M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$0
3
GPP
3
Great Point Partners
Connecticut
$0
4
APM
4
Avidity Partners Management
Texas
$19.5M
5
CC
5
Casdin Capital
New York
$30.6M
Name Market Value Shares Shares
Change 		Shares
Change %
WP
26
Woodline Partners
California
$5.57M 386,466 +10,189 +3%
Bank of America
27
Bank of America
North Carolina
$5.55M 384,706 -20,687 -5%
CAM
28
Cormorant Asset Management
Massachusetts
$5.05M 350,000 – –
HRCM
29
Hood River Capital Management
Florida
$4.97M 344,776 +9,361 +3%
Charles Schwab
30
Charles Schwab
California
$4.65M 322,300 +1,723 +0.5%
AG
31
Artal Group
Luxembourg
$4.33M 300,000 – –
JFG
32
Jefferies Financial Group
New York
$3.85M 267,071 -8,642 -3%
ECM
33
ExodusPoint Capital Management
New York
$3.8M 263,620 +196,276 +291%
Rafferty Asset Management
34
Rafferty Asset Management
New York
$3.79M 263,038 -109,643 -29%
Goldman Sachs
35
Goldman Sachs
New York
$3.79M 262,943 -131,291 -33%
GW
36
GW & Wade
Massachusetts
$3.74M 259,626 -11 -0%
Morgan Stanley
37
Morgan Stanley
New York
$3.47M 240,821 +143,878 +148%
PHS
38
PFM Health Sciences
California
$2.68M 186,087 -31,215 -14%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$2.47M 171,149 -3,243 -2%
Mirae Asset Global Investments
40
Mirae Asset Global Investments
South Korea
$2.44M 168,946 +12,165 +8%
CSS
41
Cubist Systematic Strategies
Connecticut
$2.42M 168,126 +111,004 +194%
Nuveen Asset Management
42
Nuveen Asset Management
Illinois
$2.32M 160,724 -27,750 -15%
Jane Street
43
Jane Street
New York
$2.23M 154,590 +140,774 +1,019%
TC
44
TwinBeech Capital
New York
$2.07M 143,520 +80,177 +127%
Two Sigma Investments
45
Two Sigma Investments
New York
$2.04M 141,756 +141,756 New
Squarepoint
46
Squarepoint
New York
$1.81M 125,440 +82,945 +195%
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
$1.71M 118,438 +45,019 +61%
Barclays
48
Barclays
United Kingdom
$1.57M 108,846 -93,543 -46%
UBS Group
49
UBS Group
Switzerland
$1.31M 90,835 -152,939 -63%
AllianceBernstein
50
AllianceBernstein
Tennessee
$1.14M 78,770 -100 -0.1%
1
2
3 4 5